Digital behavioral health startup Done said it "disagrees" with criminal charges filed against its founder and CEO Ruthia He and clinical president Dr. David Brody.
Done, sometimes called Done Global or Done Health, said in a statement posted to its website Tuesday it is continuing normal operations following last week's arrest of He and Brody over allegations including fraud.
Read more: ADHD startup CEO, clinical president arrested over alleged fraud
"Done Global will continue to operate," the statement said.
Done connects patients with clinicians who can prescribe medications like Adderall to treat attention deficit hyperactivity disorder.
Both He and Brody face seven counts related to healthcare fraud, controlled substance distribution and obstruction of justice, according to an indictment filed last week in a California federal court. The two Done employees allegedly conspired to provide prescriptions that were not for legitimate medical purposes, among other allegations outlined in court documents.
The company said in the statement that its clinicians operate independently and it does not improperly influence them on medication prescriptions.
Done said it is "fully aligned" with the Drug Enforcement Administration and Justice Department on eliminating drug abuse in the United States.
The company said it will do everything in its power to ensure its patient customers continue to receive access to care.
Brody pleaded not guilty on all counts and was released Thursday after posting an unsecured bond of $250,000, according to court documents.
"Dr. Brody worked to promote access to medical treatment for those with ADHD in the face of both widespread stigma and the unprecedented challenges of a global pandemic. We look forward to presenting his case in court," Brody's lawyer said in a statement.
Ruthia He was scheduled to appear in court in Los Angeles Thursday, according to the Justice Department. Information about her arraignment was not yet publicly available.
Attempts to reach Done's media contact were not successful. Brody and He did not respond to requests for comment.
Last week, the Centers for Disease Control and Prevention released a Health Alert Network Health Advisory regarding the indictment about “potential disrupted access to care."
According to the agency, as many as 50,000 adult patients across all states could be affected.
"Patients who rely on prescription stimulant medications to treat their ADHD and have been using this or other similar subscription-based telehealth platforms could experience a disruption to their treatment and disrupted access to care," the advisory said.
